OnKure Therapeutics Inc. (OKUR)
NASDAQ: OKUR
· Real-Time Price · USD
2.87
0.34 (13.44%)
At close: Aug 18, 2025, 3:05 PM
OnKure Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 212K | 212K | 419K | 12K | 12K | 151K | 291K | 43K | n/a | n/a |
Gross Profit | -212K | -212K | -419K | -12K | -12K | -151K | -291K | -43K | n/a | n/a |
Operating Income | -16.32M | -17M | -33.8M | -4.66M | -14.34M | -9.83M | 21.11M | -20.89M | -8.63M | -8.75M |
Interest Income | 934K | 1.07M | n/a | n/a | 230K | 295K | n/a | n/a | 451K | 73K |
Pretax Income | -15.39M | -15.93M | -35.19M | -3.69M | -14.14M | -9.54M | 18.52M | -19.2M | -8.18M | -8.68M |
Net Income | -15.39M | -15.93M | -35.19M | -3.69M | -14.14M | -9.54M | 18.52M | -19.2M | -8.18M | -8.68M |
Selling & General & Admin | 3.62M | 3.99M | -3.56M | 3.76M | 3.59M | 1.26M | -14.22M | 7.27M | 1.12M | 1.23M |
Research & Development | 12.5M | 13.01M | 37.36M | 904K | 10.75M | 8.57M | -6.89M | 13.62M | 7.51M | 7.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.11M | 17M | 33.8M | 4.66M | 14.34M | 9.83M | -21.11M | 20.89M | 8.63M | 8.75M |
Interest Expense | n/a | n/a | n/a | n/a | 26K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.32M | 17M | 33.8M | 4.66M | 14.34M | 9.83M | -21.11M | 20.89M | 8.63M | 8.75M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 13.51M | 13.42M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M |
Shares Outstanding (Diluted) | 13.51M | 13.42M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M | 13.34M |
EPS (Basic) | -1.14 | -1.19 | -2.64 | -0.28 | -1.06 | -0.71 | 1.39 | -1.44 | -0.61 | -0.65 |
EPS (Diluted) | -1.14 | -1.19 | -2.64 | -0.28 | -1.06 | -0.71 | 1.39 | -1.44 | -0.61 | -0.65 |
EBITDA | -15.18M | -16.79M | -31.16M | 3.09M | -13.96M | -9.68M | 21.55M | -39.65M | -8.03M | -8.62M |
EBIT | -15.39M | -17M | -31.78M | 3.35M | -14.11M | -9.83M | 21.11M | -39.49M | -8.18M | -8.75M |
Depreciation & Amortization | 212K | 212K | 622K | -259K | 148K | 151K | 434K | -157K | 155K | 128K |